首页> 外国专利> STRAIN OF BACTERIUM LACTOBACILLUS ACIDOPHILUS NV EP 317/402 'NARINE' TNCI USED FOR PREPARING CURATIVE-PROPHYLACTIC PREPARATIONS FOR INTESTINE MICROFLORA NORMALIZATION

STRAIN OF BACTERIUM LACTOBACILLUS ACIDOPHILUS NV EP 317/402 'NARINE' TNCI USED FOR PREPARING CURATIVE-PROPHYLACTIC PREPARATIONS FOR INTESTINE MICROFLORA NORMALIZATION

机译:乳酸菌乳酸杆菌NV EP 317/402“ NARINE” TNCI菌株,用于制备肠道小花正常化的促营养性制剂

摘要

FIELD: biotechnology, microbiology. SUBSTANCE: invention relates to the strain of lactobacillus showing ability to produce interferon in human unicellular cells and to effect on physiological and immunological processes in body. The strain Lactobacillus acidophilus N.V.EP 317/402 "Narine" TNCi is deposited in VKPM at N B-8017. The strain is obtained by of many years selection of the parent culture L. acidophilus N.V. 317/402 "Narine". The strain is selected by its antibiotic activity to pathogens of gastroenteric diseases, resistance to antibiotics, vitamin producing capacity, growth rate and so on. Ferment of the strain L. acidophilus N.V.EP 317/402 "Narine" TNCi can be used for preparing dietetic and curative foodstuffs or for direct use in nutrition, as medicinal agent for treatment and prophylaxis of dysbacteriosis and its complications. EFFECT: strain indicated above, enhanced effectiveness of preparations. 4 dwg, 3 tbl, 2 ex
机译:领域:生物技术,微生物学。本发明涉及乳酸杆菌菌株,该菌株显示出在人单细胞中产生干扰素并影响人体生理和免疫过程的能力。嗜酸乳杆菌N.V.EP 317/402“ Narine” TNCi菌株在VKPM中保藏在N B-8017。通过多年选择亲本培养嗜酸乳杆菌N.V.317 / 402“ Narine”获得菌株。通过对胃肠道病原体的抗生素活性,对抗生素的抗性,维生素产生能力,生长速率等来选择菌株。嗜酸乳杆菌N.V.EP 317/402“ Narine” TNCi菌株的发酵可用于制备营养食品和治疗性食品或直接用于营养,作为治疗和预防细菌性病及其并发症的药物。效果:以上指示的菌株,增强了制剂的有效性。 4桶,3汤匙,2桶

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号